The efficacy and safety of managing ectopic pregnancies with transvaginal ultrasound-guided local injections of absolute ethanol
- PMID: 16832599
- PMCID: PMC3506374
- DOI: 10.1007/s10815-006-9037-1
The efficacy and safety of managing ectopic pregnancies with transvaginal ultrasound-guided local injections of absolute ethanol
Abstract
Purpose: To describe the efficacy and safety of managing ectopic pregnancies (EP) with ultrasound-guided local injections of absolute ethanol (AE).
Methods: 69 cases of EP following IVF performed in our clinic were treated with a local injection of 0.3 ml AE with a 23-gauge needle under transvaginal ultrasonic guidance. The efficacy was evaluated comparing serum beta-human chorionic gonadotropin (beta-hCG) levels before and after the injection.
Results: In the 60 successful cases (87%), the serum beta-hCG level decreased by 10-30% in two hours postinjection. Of these, 46 were effective with a single injection and the half-life of beta-hCG was achieved within 4 days in 45 cases. In 56 cases (including repetitive administration) serum beta-hCG levels decreased to 20 mIU/mL within 20 days. The treatment showed no side effects and could be given on an outpatient basis without anesthesia.
Conclusions: This method was shown to be a safe, effective new approach to treating EP.
Figures
References
-
- Darai E, Benifla JL, Naouri M, Pennehouat G, Guglielmina JN, Deval B, Filippini F, Crequat J, Madelenat P. Transvaginal intratubal methotrexate treatment of ectopic pregnancy. Report of 100 cases. Hum Reprod. 1995;11(2):420–424. - PubMed
